Course Information

Release date: November 26, 2025
Expiration date: November 26, 2026
Estimated time to complete activity: 60 minutes

PROVIDER STATEMENT

This activity is provided by Integrity CE, LLC.

DISCLOSURE OF COMMERCIAL SUPPORT

This activity is supported by an educational grant from Novo Nordisk, Inc.

PROGRAM OVERVIEW

In the United States, overweight and obesity are highly prevalent, with 70% of American adults affected by either condition. Overweight and obesity are associated with multiple potential medical complications, including metabolic-associated steatohepatitis (MASH), osteoarthritis, obstructive sleep apnea, type 2 diabetes, and cardiovascular complications, among others. Recognition of the potential complications of overweight and obesity, along with respectful, nonstigmatizing discussion and implementation of novel management strategies, are crucial to improving outcomes for patients.

Join experts Karli Burridge, PA-C, MMS, FOMA, Deborah B. Horn, DO, MPH, FOMA, Javier Morales MD, FACP, FACE, and Erin D. Michos, MD, MHS for a CME-accredited activity on diagnosis, management, and respectful discussion of the medical implications of overweight and obesity.

Learning Objectives

TARGET AUDIENCE

This educational activity has been designed to meet the needs of primary care clinicians including physicians, nurse practitioners, physician associates, and allied healthcare professionals involved in the management of patients with overweight and obesity.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Recognize the burdens of overweight and obesity and related comorbidities
Evaluate the role of current and emerging pharmacotherapy along with lifestyle change in development of comprehensive treatment plans for patients
Summarize best practices for discussing overweight and obesity with patients in a respectful and nonstigmatizing manner

Faculty Information and Disclosures

FACULTY

	Karli Burridge, PA-C, MMS, FOMA Founder, Gaining Health Director of Clinical Education, Healthy4Life Naperville, Illinois
	Deborah B. Horn, DO, MPH, MFOMA (Chair) Director, Center for Obesity Medicine and Metabolic Performance Program Director, Allison Family Foundation Clinical Obesity Medicine Fellowship University of Texas Professor of Surgery University of Texas McGovern Medical School Houston, Texas
	Erin D. Michos, MD, MHS Professor of Medicine Director of Women’s Cardiovascular Health Associate Director of Preventive Cardiology Core Faculty, Advanced Lipid Clinic Division of Cardiology Johns Hopkins University School of Medicine Baltimore, Maryland
	Javier Morales, MD, FACP, FACE Associate Clinical Professor of Medicine Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Vice President Advanced Internal Medicine Group, P.C. East Hills, New York

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated. The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

Karli Burridge, PA-C, MMS, FOMA

Advisory Boards: Boehringer Ingelheim, Currax, Eli Lilly, Novo Nordisk

Speaker: Boehringer Ingelheim, Currax, Eli Lilly, Vivus

Deborah B. Horn, DO, MPH, MFOMA

Deborah B. Horn, DO, MPH, MFOMA does not have any financial relationships or relationships to products or devices with ineligible companies.

Erin D. Michos, MD, MHS

Consultant: Arrowhead, Bayer, Boehringer Ingelheim, Edwards Lifescience, Eli Lilly, Ionis, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer

Javier Morales, MD, FACP, FACE

Consultant: Kailera

Consultant and Speaker: Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk,

Speaker: Amben, Kailera, Pfizer

The Integrity CE, LLC planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of November 26, 2025 through November 26, 2026, participants must:

Read the learning objectives
Complete the pretest
Study the educational activity
Complete the posttest and the evaluation form

A statement of credit will issued by our system and immediately available for download upon receipt of a completed posttest with a score of 40% or better and a completed activity evaluation form.

ACCREDITATION STATEMENT

Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity CE, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements

MEDIA

Internet

PRIVACY POLICY

When you register or participate in an educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and… (continued)

MINIMUM SYSTEM REQUIREMENTS

Internet: Stable connection
Operating Systems: Windows 10/macOS 10.14 or later recommended
Web Browser: Latest versions of Google Chrome, Microsoft Edge, or Safari recommended (other modern browsers also supported)
Plug-ins: No plug-ins required

For optimal performance and security, ensure your browser is up to date and avoid using unsupported or outdated versions

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Release date: November 26, 2025Expiration date: November 26, 2026Estimated time to complete activity: 60 minutes

Around the Horn on Obesity Management: Identifying Real-World Solutions to Long-Term Challenges